Both in Pharmaceuticals
Cingulate vs Rani Therapeutics Holdings
Over the past year CING returned +32.4% and RANI returned −66.0%; their daily moves had a correlation of 0.13.
CING +32.4% RANI −66.0%Growth of $1, one year, split-adjusted
| Metric | CING | RANI |
|---|---|---|
| Price | $4.98 | $0.6059 |
| Market cap | $72.4M | $69.9M |
| Today | +6.87% | +3.11% |
| 1 month | −1.6% | −19.1% |
| 6 months | −9.0% | −35.5% |
| Year to date | +14.7% | −55.1% |
| 1 year | +36.4% | −74.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −432.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 14.3× |
| Net cash | $23.3M | $53.4M |
| Dividend yield | — | — |
| Volatility (60d) | 40.7% | 64.1% |
| Short % of float | 11.6% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).